Our Vision

Our Vision

Our vision is a world without breast cancer.
Working Toward a Cure for All Cases of Breast Cancer

For the benefit of all patients and their families whose lives have been or will be affected by breast cancer, the JBCRG is working to improve breast cancer treatment and outcomes. Our ultimate aim is a world in which all cases of breast cancer are curable and no more lives are lost to this disease.

Our Principles

  • We conduct research in a way that ensures the scientific validity of our findings.
  • The human rights of patients with breast cancer are our top priority. Our research is conducted in accordance with national and international ethical standards.
  • We are committed to transparency regarding the funding of our research.

Greetings

Norikazu Masuda

The Japan Breast Cancer Research Group (JBCRG) has contributed to the progress of health care for breast cancer patients nationally and internationally through its clinical researches that have lauded remarkable achievements, including a response-guided treatment strategy for primary breast cancer using neoadjuvant therapy, new therapeutic strategies for advanced/recurrent breast cancer, and real-world evidence capturing the unmet needs of breast cancer patients. Moreover, as a member of the Breast International Group (BIG), the world’s largest international network of academic research groups for breast cancer, JBCRG has been active in collaborative research projects, cooperating with a number of international study groups, which aim to bring innovations to breast cancer care at a global perspective.

Based on our abundant experience in clinical and translational researches, we will further promote researches on new technologies and therapeutic approaches, which will give us valuable scientific insights to make breakthroughs in clinical outcomes.

Our mission is to develop the best treatment for every person suffering from breast cancer. Carrying on the footsteps of the great former Representative Directors, Dr. Masakazu Toi and Dr. Shinji Ohno, I feel the magnitude of the responsibility to meet the expectations toward JBCRG as it enters into its full maturity. I will dedicate myself to this role and exert my knowledge and experience to the fullest extent. I sincerely ask those who are concerned in our fight against breast cancer for your continuous support and cooperation in pursuing our challenges.

Norikazu Masuda, M.D., Ph.D.
Representative Director, JBCRG
(Department of Breast Surgery, Kyoto University Graduate School of Medicine)

Organizational chart

Officers list

Represen
tative
Director

Norikazu Masuda

Kyoto University Graduate School of
Medicine

Executive Director

Shigehira Saji

Fukushima Medical University


Hiroshi Ishiguro

Saitama Medical University International Medical Center


Chikako Shimizu

National Center for Global Health and Medicine


Takahiro Nakayama

Osaka International Cancer Institute


Yasuaki Sagara

Sagara Hospital

Director

Kenjiro Aogi

Shikoku Cancer Center


Koichiro Tsugawa

St Marianna University School of Medicine


Yutaka Yamamoto

Graduate School of Medical Sciences Kumamoto University


Toshinari Yamashita

Kanagawa Cancer Center


Shoichiro Ohtani

Ohtani Shoichiro Breast Clinic


Takayuki Ueno

Cancer Institute Hospital of JFCR


Takanori Ishida

Graduate School of Medicine, Tohoku University


Hiroko Tamura Bando

Institute of Clinical Medicine University of Tsukuba


Manabu Futamura

Gifu University Hospital


Masato Takahashi

Hokkaido University Hospital


Eriko Kitao Tokunaga

Kyushu Cancer Center


Masahiro Takada

Kansai Medical University


Tetsuhiro Yoshinami

Osaka University Hospital

Auditor

Katsumasa Kuroi
Tokyo Metropolitan Tama Medical Center

Shinji Ohno
Sagara Hospital

Honorary Advisor

Masakazu Toi
Tokyo Metropolitan Komagome Hospital